Similar sites
Category
N/AGlobal Rank
N/ARank in 1 month
0Estimate Value
N/A
#gazon ombre
#magellan
#magellan bio
#chaux magnésienne
#zucchini courgette
#noire de crimée tomates anciennes
#tomate rose de berne
#agastache rugosa
#saine abondance
#larves coccinelles
#larve de coccinelle
#biotop
#ultrason
#effaroucheur
#root pouch
#perlite
Category
Food and DrinkGlobal Rank
N/ARank in 1 month
86.1KEstimate Value
N/ASorry. Description is not currently available
Category
N/AGlobal Rank
N/ARank in 1 month
0Estimate Value
N/A
Category
N/AGlobal Rank
N/ARank in 1 month
0Estimate Value
N/AMonjoven | Hair Transplant & Cosmetic Surgery Clinic
Category
InvestingGlobal Rank
N/ARank in 1 month
63.6KEstimate Value
N/ASorry. Description is not currently available
Category
N/AGlobal Rank
N/ARank in 1 month
0Estimate Value
N/A文章を方言やオモシロ語に変換! いつもと違う文章で驚かせちゃえ! 言葉変換サイト『もんじろう』
#ないない 顔文字
#お辞儀 顔文字
#きゃっきゃ 顔文字
#ナイナイ 顔文字
#もんじろう
#顔文字 笑顔
#aa コピペ
#泣く 顔文字
#顔文字 汗
#アスキーアート コピペ
#顔文字 痛い
#顔文字 キラン
#顔文字 ふぅ
#かに 顔文字
#口笛 顔文字
#顔文字
#顔文字 一覧
#にこ 顔文字
#ぎゅ 顔文字
#ぺこり 顔文字
#おはよう 顔文字 かわいい
#投げる 顔文字
#キーワード
#文章変換 ジェネレーター
#武士語 変換
#アフロ 顔文字
#方言 変換
Category
Marketing and AdvertisingGlobal Rank
N/ARank in 1 month
85.9KEstimate Value
N/ASorry. Description is not currently available
#monji 保存期間
Malware Scan Info
Macafee Check :
Email address with monjuvi.com
Recent Searched Sites
Gays.run (1 mins ago) / US
Mazureklawoffice.com (46 seconds ago) / US
Meforwe.com (4 seconds ago) / VG
Losdelamusica.com (5 seconds ago) / US
Tireworldkan.com (1 mins ago) / JP
Wyseminds.com (1 mins ago) / US
Prestontimesonline.com (2 seconds ago) / US
Ceodelhi.nic.in (21 seconds ago) / IN
Villagefocus.org (2 seconds ago) / US
Los-deportes.info (12 seconds ago) / US
Jp19vlog.com (6 seconds ago) / JP
Ai-mori-d-oriente-hotel-venice.ibooked.dk (18 seconds ago) / US
Regiaonoroeste.com (19 seconds ago) / US
Arenaschool.com (9 seconds ago) / US
Yongmai.com (5 seconds ago) / US
Sachtinhhoa.vn (18 seconds ago) / VN
Dark-liver-horses.colorcode.is (29 seconds ago) / CA
Eera-eeip.eu (1 mins ago) / BE
Monjuvi.com (0 seconds ago) / US
Karoserija.me (4 seconds ago) / US
Domain Informations
Monjuvi.com lookup results from whois.corporatedomains.com server:
- Domain created: 2018-04-28T18:06:41Z
- Domain updated: 2024-04-17T04:16:25Z
- Domain expires: 2025-04-28T18:06:41Z 0 Years, 297 Days left
- Website age: 6 Years, 67 Days
- Registrar Domain ID: 2257850897_DOMAIN_COM-VRSN
- Registrar Url: http://cscdbs.com
- Registrar WHOIS Server: whois.corporatedomains.com
- Registrar Abuse Contact Email: [email protected]
- Registrar Abuse Contact Phone: 8887802723
- Name server:
- DNS1.CSCDNS.NET
- DNS2.CSCDNS.NET
Network
- inetnum : 20.33.0.0 - 20.128.255.255
- name : MSFT
- handle : NET-20-33-0-0-1
- status : Direct Allocation
- created : 1998-07-10
- changed : 2024-03-18
- desc : To report suspected security issues specific to traffic emanating from Microsoft online services, including the distribution of malicious content or other illicit or illegal material through a Microsoft online service, please submit reports to:,* https://cert.microsoft.com.,For SPAM and other abuse issues, such as Microsoft Accounts, please contact:,* [email protected].,To report security vulnerabilities in Microsoft products and services, please contact:,* [email protected].,For legal and law enforcement-related requests, please contact:,* [email protected],For routing, peering or DNS issues, please,contact:,* [email protected]
Owner
- organization : Microsoft Corporation
- handle : MSFT
- address : Array,Redmond,WA,98052,US
Technical support
- handle : SINGH683-ARIN
- name : Singh, Prachi
- phone : +1-425-707-5601
- email : [email protected]
Abuse
- handle : MAC74-ARIN
- name : Microsoft Abuse Contact
- phone : +1-425-882-8080
- email : [email protected]
Domain Provider | Number Of Domains |
---|---|
godaddy.com | 680673 |
namecheap.com | 224815 |
networksolutions.com | 166289 |
tucows.com | 137788 |
publicdomainregistry.com | 87644 |
whois.godaddy.com | 62197 |
enomdomains.com | 58093 |
cloudflare.com | 50063 |
namesilo.com | 48725 |
gmo.jp | 46243 |
register.com | 38933 |
fastdomain.com | 38170 |
ionos.com | 33870 |
name.com | 32166 |
wildwestdomains.com | 32165 |
net.cn | 30887 |
registrar.amazon.com | 30450 |
dynadot.com | 28168 |
key-systems.net | 27147 |
Host Informations
Host name | 20.49.104.33 |
IP address | 20.49.104.33 |
Location | United States |
Latitude | 37.751 |
Longitude | -97.822 |
Timezone | America/Chicago |
Port Scanner (IP: 20.49.104.33)
Spam Check (IP: 20.49.104.33) › Dnsbl-1.uceprotect.net:
› Dnsbl-2.uceprotect.net:
› Dnsbl-3.uceprotect.net:
› Dnsbl.dronebl.org:
› Dnsbl.sorbs.net:
› Spam.dnsbl.sorbs.net:
› Bl.spamcop.net:
› Recent.dnsbl.sorbs.net:
› All.spamrats.com:
› B.barracudacentral.org:
› Bl.blocklist.de:
› Bl.emailbasura.org:
› Bl.mailspike.org:
› Bl.spamcop.net:
› Cblplus.anti-spam.org.cn:
› Dnsbl.anticaptcha.net:
› Ip.v4bl.org:
› Fnrbl.fast.net:
› Dnsrbl.swinog.ch:
› Mail-abuse.blacklist.jippg.org:
› Singlebl.spamgrouper.com:
› Spam.abuse.ch:
› Spamsources.fabel.dk:
› Virbl.dnsbl.bit.nl:
› Cbl.abuseat.org:
› Dnsbl.justspam.org:
› Zen.spamhaus.org:
Keyword Suggestion
Site Inspections
Websites Listing
We found Websites Listing below when search with monjuvi.com on Search Engine
MONJUVI® (tafasitamab-cxix): Treatment for R/R DLBCL
MONJUVI® (tafasitamab-cxix) 200 mg for injection, targeted immunotherapy for intravenous use in R/R DLBCL and recommended by NCCN Guidelines®. Please see efficacy and safety data …
Monjuvihcp.comDA: 18 PA: 18 MOZ Rank: 19
Monjuvi (tafasitamab-cxix) Prescribing Information
1r lqfrpsdwlelolwlhv kdyhehhq revhuyhg ehwzhhq 021-89, zlwk lqixvlrq frqwdlqhuv pdgh ri sro\surs\ohqh 33 sro\ylq\ofkorulgh 39& sro\hwk\ohqh 3( sro\hwk\ohqwhuhskwkdodwh
Monjuvi.comDA: 15 PA: 18 MOZ Rank: 34
Billing & Coding | MONJUVI® (tafasitamab-cxix): Treatment for …
MONJUVI is initially administered in combination with lenalidomide. The combination of MONJUVI with lenalidomide is contraindicated in pregnant women because …
Monjuvihcp.comDA: 18 PA: 19 MOZ Rank: 39
Monjuvi - FDA prescribing information, side effects and uses
Withhold Monjuvi and lenalidomide and monitor complete blood count (CBC) weekly until platelet count is 50,000/mcL or higher. Resume Monjuvi at the same dose and …
Drugs.comDA: 13 PA: 17 MOZ Rank: 33
Monjuvi (Tafasitamab-cxix Injection ): Uses, Dosage, Side …
MONJUVI (tafasitamab-cxix) for injection is a sterile, preservative-free, white to slightly yellowish lyophilized powder for reconstitution supplied as a 200 mg single-dose vial. …
Rxlist.comDA: 14 PA: 17 MOZ Rank: 35
Monjuvi: How it works, side effects, cost, uses, and more
Monjuvi (tafasitamab-cxix) is a prescription infusion used to treat diffuse large B cell lymphoma. Learn about how it works, side effects, cost, uses, and more.
Medicalnewstoday.comDA: 24 PA: 23 MOZ Rank: 52
Buy Monjuvi (tafasitamab-cxix) Online - TheSocialMedwork
Monjuvi (tafasitamab-cxix) is a Fc-modified monoclonal antibody (immunotherapy) that can bind to the CD19 antigen. CD19 is a type of protein that is present on the surface of white blood …
Thesocialmedwork.comDA: 20 PA: 25 MOZ Rank: 51
MorphoSys Reports Preliminary 2021 Monjuvi U.S. Sales and …
- Preliminary 2021 Monjuvi U.S. net product sales of US$ 79.1 million (€ 66.9 million) - Anticipated 2022 Monjuvi U.S. net product sales in the range of US$ 110 to 135 …
Morphosys.comDA: 17 PA: 50 MOZ Rank: 43
Monjuvi Intravenous: Uses, Side Effects, Interactions, Pictures
Monjuvi 200 Mg Intravenous Solution Antineoplastic Monoclonal Antibodies - Uses, Side Effects, and More Generic Name(S): tafasitamab-cxix View Free Coupon
Webmd.comDA: 13 PA: 48 MOZ Rank: 69
Tafasitamab-cxix (Monjuvi® ) | OncoLink
About: Tafasitamab-cxix (Monjuvi®) Tafasitamab-cxix is a monoclonal antibody. Monoclonal antibodies are created in a lab to attach to the targets found on specific types of …
Oncolink.orgDA: 16 PA: 50 MOZ Rank: 81
Monjuvi (tafasitamab) dosing, indications, interactions, adverse ...
Defined as a neutrophil count ≤500/mcL, or neutrophil count ≤1,000/mcL for ≥7 days, or with an increase of body temperature ≥100.4ºF (38ºC) Withhold tafasitamab and lenalidomide and …
Reference.medscape.comDA: 22 PA: 33 MOZ Rank: 65
FDA Approves Monjuvi(R) (tafasitamab-cxix) in Combination with ...
- FDA granted Monjuvi Fast Track, Breakthrough Therapy and Priority Review designations - MorphoSys and Incyte will co-commercialize Monjuvi in the United States - …
Ca.news.yahoo.comDA: 17 PA: 50 MOZ Rank: 78
HIGHLIGHTS OF PRESCRIBING INFORMATION ...
Continue MONJUVI as monotherapy until disease progression or unacceptable toxicity [see Clinical Studies (14)]. Refer to the lenalidomide prescribing information for lenalidomide …
Accessdata.fda.govDA: 22 PA: 45 MOZ Rank: 79
MorphoSys Reports Preliminary 2021 Monjuvi U.S. Sales and …
About Monjuvi (R) (tafasitamab) Tafasitamab is a humanized Fc-modified cytolytic CD19 targeting monoclonal antibody. In 2010, MorphoSys licensed exclusive worldwide rights …
Ca.finance.yahoo.comDA: 20 PA: 50 MOZ Rank: 96
MorphoSys to Present New Data on Pelabresib and Monjuvi® …
BOSTON, May 12, 2022--MorphoSys AG (FSE: MOR; NASDAQ: MOR) announced that new data on pelabresib and tafasitamab, marketed in the U.S. as Monjuvi® and in …
Ca.movies.yahoo.comDA: 19 PA: 50 MOZ Rank: 90
MorphoSys to Present New Data on Pelabresib and Monjuvi® …
Media Release BOSTON, Mass., USA, May 12, 2022. MorphoSys to Present New Data on Pelabresib and Monjuvi ® (tafasitamab-cxix) at the 2022 European Hematology …
Morphosys.comDA: 17 PA: 50 MOZ Rank: 35
Monjuvi approval in relapsed/refractory DLBCL could lead home …
Monjuvi could represent a safer, more effective, and affordable option to CD19 targeting, with potential use across different treatment settings, as well as offer an alternative …
Globaldata.comDA: 18 PA: 50 MOZ Rank: 34
MorphoSys to Present New Data on Pelabresib and Monjuvi® …
BOSTON, May 12, 2022--MorphoSys AG (FSE: MOR; NASDAQ: MOR) announced that new data on pelabresib and tafasitamab, marketed in the U.S. as Monjuvi® and in …
Finance.yahoo.comDA: 17 PA: 50 MOZ Rank: 96
Monjuvi - Side Effects, Interactions, Uses, Dosage, Warnings
Find everything you need to know about Monjuvi, including what it is used for, warnings, reviews, side effects, and interactions. Learn more about Monjuvi at …
Everydayhealth.comDA: 22 PA: 14 MOZ Rank: 54
FDA Approves Monjuvi(R) (tafasitamab-cxix) in Combination with ...
The Biologics License Application (BLA) for Monjuvi was granted Priority Review and approved under the FDA's Accelerated Approval program. Monjuvi is expected to be …
Ca.finance.yahoo.comDA: 20 PA: 50 MOZ Rank: 94
Domains Expiration Date Updated
Site | Provider | Expiration Date |
---|---|---|
chinese-cliff.com | gmo.jp | 333 Days |